Serum interleukin-1 (IL-1) activity in alcoholic hepatitis

Craig J. McClain, Donald A. Cohen, Charles A. Dinarello, Joseph Gerard Cannon, Steven I. Shedlofsky, Alan M. Kaplan

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Interleukin-1 (IL-1) is a monokine which has been demonstrated to produce a variety of seemingly diverse metabolic events including fever, neutrophilia, anorexia, altered mineral metabolism, muscle catabolism, and fibroblast proliferation. Because many of the clinical features of alcoholic hepatitis are metabolic abnormalities that have been shown to be caused by IL-1, we questioned whether patients with alcoholic hepatitis had elevated serum levels of IL-1 Six patients with alcoholic hepatitis had serum IL-1 activity measured by the thymocyte costimulator assay after serum inhibitors were removed. Their values were compared to those of 6 age and sex-matched healthy controls. Patients with alcoholic hepatitis had markedly elevated serum IL-1 activity, with the integrated value of all fractions having serum IL-1 activity being 9.8 times that of controls. IL-1 activity in serum from alcoholic hepatitis patients also was blocked by antibody to IL-1. We conclude that patients with alcoholic hepatitis have increased serum IL-1 activity which may play a role in certain of the metabolic complications of alcoholic hepatitis.

Original languageEnglish (US)
Pages (from-to)1479-1485
Number of pages7
JournalLife Sciences
Volume39
Issue number16
DOIs
StatePublished - Oct 20 1986

Fingerprint

Alcoholic Hepatitis
Interleukin-1
Serum
Monokines
Anorexia
Thymocytes
Fibroblasts
Metabolism
Minerals
Muscle
Assays
Fever
Muscles

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

McClain, C. J., Cohen, D. A., Dinarello, C. A., Cannon, J. G., Shedlofsky, S. I., & Kaplan, A. M. (1986). Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sciences, 39(16), 1479-1485. https://doi.org/10.1016/0024-3205(86)90554-0

Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. / McClain, Craig J.; Cohen, Donald A.; Dinarello, Charles A.; Cannon, Joseph Gerard; Shedlofsky, Steven I.; Kaplan, Alan M.

In: Life Sciences, Vol. 39, No. 16, 20.10.1986, p. 1479-1485.

Research output: Contribution to journalArticle

McClain, CJ, Cohen, DA, Dinarello, CA, Cannon, JG, Shedlofsky, SI & Kaplan, AM 1986, 'Serum interleukin-1 (IL-1) activity in alcoholic hepatitis', Life Sciences, vol. 39, no. 16, pp. 1479-1485. https://doi.org/10.1016/0024-3205(86)90554-0
McClain CJ, Cohen DA, Dinarello CA, Cannon JG, Shedlofsky SI, Kaplan AM. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sciences. 1986 Oct 20;39(16):1479-1485. https://doi.org/10.1016/0024-3205(86)90554-0
McClain, Craig J. ; Cohen, Donald A. ; Dinarello, Charles A. ; Cannon, Joseph Gerard ; Shedlofsky, Steven I. ; Kaplan, Alan M. / Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. In: Life Sciences. 1986 ; Vol. 39, No. 16. pp. 1479-1485.
@article{e89686cee32d4492a42749c38d913cc4,
title = "Serum interleukin-1 (IL-1) activity in alcoholic hepatitis",
abstract = "Interleukin-1 (IL-1) is a monokine which has been demonstrated to produce a variety of seemingly diverse metabolic events including fever, neutrophilia, anorexia, altered mineral metabolism, muscle catabolism, and fibroblast proliferation. Because many of the clinical features of alcoholic hepatitis are metabolic abnormalities that have been shown to be caused by IL-1, we questioned whether patients with alcoholic hepatitis had elevated serum levels of IL-1 Six patients with alcoholic hepatitis had serum IL-1 activity measured by the thymocyte costimulator assay after serum inhibitors were removed. Their values were compared to those of 6 age and sex-matched healthy controls. Patients with alcoholic hepatitis had markedly elevated serum IL-1 activity, with the integrated value of all fractions having serum IL-1 activity being 9.8 times that of controls. IL-1 activity in serum from alcoholic hepatitis patients also was blocked by antibody to IL-1. We conclude that patients with alcoholic hepatitis have increased serum IL-1 activity which may play a role in certain of the metabolic complications of alcoholic hepatitis.",
author = "McClain, {Craig J.} and Cohen, {Donald A.} and Dinarello, {Charles A.} and Cannon, {Joseph Gerard} and Shedlofsky, {Steven I.} and Kaplan, {Alan M.}",
year = "1986",
month = "10",
day = "20",
doi = "10.1016/0024-3205(86)90554-0",
language = "English (US)",
volume = "39",
pages = "1479--1485",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "16",

}

TY - JOUR

T1 - Serum interleukin-1 (IL-1) activity in alcoholic hepatitis

AU - McClain, Craig J.

AU - Cohen, Donald A.

AU - Dinarello, Charles A.

AU - Cannon, Joseph Gerard

AU - Shedlofsky, Steven I.

AU - Kaplan, Alan M.

PY - 1986/10/20

Y1 - 1986/10/20

N2 - Interleukin-1 (IL-1) is a monokine which has been demonstrated to produce a variety of seemingly diverse metabolic events including fever, neutrophilia, anorexia, altered mineral metabolism, muscle catabolism, and fibroblast proliferation. Because many of the clinical features of alcoholic hepatitis are metabolic abnormalities that have been shown to be caused by IL-1, we questioned whether patients with alcoholic hepatitis had elevated serum levels of IL-1 Six patients with alcoholic hepatitis had serum IL-1 activity measured by the thymocyte costimulator assay after serum inhibitors were removed. Their values were compared to those of 6 age and sex-matched healthy controls. Patients with alcoholic hepatitis had markedly elevated serum IL-1 activity, with the integrated value of all fractions having serum IL-1 activity being 9.8 times that of controls. IL-1 activity in serum from alcoholic hepatitis patients also was blocked by antibody to IL-1. We conclude that patients with alcoholic hepatitis have increased serum IL-1 activity which may play a role in certain of the metabolic complications of alcoholic hepatitis.

AB - Interleukin-1 (IL-1) is a monokine which has been demonstrated to produce a variety of seemingly diverse metabolic events including fever, neutrophilia, anorexia, altered mineral metabolism, muscle catabolism, and fibroblast proliferation. Because many of the clinical features of alcoholic hepatitis are metabolic abnormalities that have been shown to be caused by IL-1, we questioned whether patients with alcoholic hepatitis had elevated serum levels of IL-1 Six patients with alcoholic hepatitis had serum IL-1 activity measured by the thymocyte costimulator assay after serum inhibitors were removed. Their values were compared to those of 6 age and sex-matched healthy controls. Patients with alcoholic hepatitis had markedly elevated serum IL-1 activity, with the integrated value of all fractions having serum IL-1 activity being 9.8 times that of controls. IL-1 activity in serum from alcoholic hepatitis patients also was blocked by antibody to IL-1. We conclude that patients with alcoholic hepatitis have increased serum IL-1 activity which may play a role in certain of the metabolic complications of alcoholic hepatitis.

UR - http://www.scopus.com/inward/record.url?scp=0022476739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022476739&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(86)90554-0

DO - 10.1016/0024-3205(86)90554-0

M3 - Article

C2 - 3490610

AN - SCOPUS:0022476739

VL - 39

SP - 1479

EP - 1485

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 16

ER -